|
FDA Approves Rituximab in Combination with Other Therapies for Untreated CLL |
|
Wednesday, 10 March 2010 17:05 |
|
The FDA recently announced approval for the monoclonal antibody rituximab in combination with fludarabine and cyclophosphamide for patients with previously untreated chronic lymphocytic leukemia (CLL) and patients with CLL who have failed on previous therapies.
|
|
Read more...
|
|
|
Herceptin Approved for HER2-positive Gastric Cancer |
|
Tuesday, 23 February 2010 15:27 |
|
Trastuzumab (Herceptin, Roche) was recently approved for use in treatment of HER2-positive gastric cancer by the European Commission. This approval is the first in the world for label extension of trastuzumab, which is already marketed for use in treatment of HER2-positive breast cancer.
|
|
Read more...
|
|
FDA Updates Warfarin Labeling |
|
Saturday, 06 February 2010 08:49 |
|
On Jan. 22, 2010, the US Food and Drug Administration (FDA) updated the "dosing and administration" labeling for the anticoagulant warfarin (Coumadin).
|
|
Read more...
|
|
FDA Approves New Use for Gardasil |
|
Tuesday, 26 January 2010 13:23 |
The Food and Drug Administration (FDA) approved a new use for the Gardasil HPV vaccine and approved a new vaccine, Cervarix, for the prevention of human papillomavirus (HPV) related cervical cancer and preneoplastic disease.
|
|
Read more...
|
|
Labs Research Automated Sample Preparation for PreservCyt |
|
Thursday, 07 January 2010 11:35 |
|
Dr. Nicholas Potter, MPLN's chief scientific officer and molecular diagnostic director, in conjunction with Qiagen, Inc. and Shiel Medical Laboratory, presented a Poster at the 2009 Association for Molecular Pathology (AMP) meeting.
|
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
|
Page 1 of 3 |
